CMS has launched an industry event, run through its Center for Clinical Standards and Quality, specifically to surface market-ready technology capabilities for its quality programs. It is called QualTech. The stated intent is to identify capabilities that can improve patient outcomes, reduce administrative burden, and expand the use of technology across CMS quality programs.
That is a federal agency stating publicly that it is looking, which is less common than it sounds.
It also fits a pattern worth naming explicitly. The CMS Health Tech Ecosystem initiative gathered commitments from hundreds of organizations and launched a first wave of patient-facing tools in April 2026. The ACCESS Model contracts technology organizations directly as model participants. Now the quality side of the agency is running an open call for capabilities. CMS has become progressively more willing to go around the traditional vendor chain and engage builders directly.
For an early stage company, that represents a genuine asymmetry. The competition is not on installed base or on an incumbent enterprise relationship. It is on whether the capability is real, and on whether the company can describe it in the agency’s own vocabulary, which is quality measures and administrative burden rather than product features.
The reason most companies will not pursue this is precisely the reason to consider it. Federal engagement looks like a distraction from commercial pipeline right up until it becomes the reference that unlocks it.